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Minute Virus of Mice (MVM), a member of the genus Parvovirus,
has a linear single-stranded negative-sense DNA genome of ~5 kb,
with small imperfect palindromes at each end that fold into hairpin
telomeres. Since incoming virions do not provide the cell with duplex
transcription templates, viral gene expression is not activated upon
nuclear entry, but instead the virus appears to remain silent until its
host cell enters S-phase under its own cell cycle control (reviewed in
Cotmore and Tattersall, 2006a, 2007). At this time, the hairpin
structure at the viral 3′ (left-end) telomere primes complementary
strand synthesis by DNA polymerase-delta (Bashir et al., 2000;
Christensen and Tattersall, 2002), creating a duplex template that
can support rapid synthesis ofmRNAs encoding the ﬁrst viral proteins,
NS1 and NS2 (Clemens and Pintel, 1988). Of these, themultifunctional
83 kDa NS1 polypeptide is absolutely required for viral replication in
all cell types, since it carries essential site-speciﬁc duplex-DNA
binding, single-strand endonuclease, and helicase elements required
for genome ampliﬁcation and progeny excision (reviewed in Cotmore
and Tattersall, 2006a,b; Nuesch, 2006). By comparison, the functions
of the 25 kDa NS2 polypeptides are poorly understood.
NS2 is the major viral protein synthesized early in S-phase, but its
accumulation relative to NS1 then declines, in part due to its relatively
short half-life (Cotmore and Tattersall, 1990; Miller and Pintel, 2001).Although not required for infection in some transformed human cell
lines, it is absolutely required in cells from the virus' natural murine
host (Cater and Pintel, 1992; Naeger et al., 1990). MVM mutants that
fail to accumulate NS2 show slightly delayed expression of the viral
NS1 protein in mouse cells, which becomes detectable in Western
blots 6 h into S-phase rather than after 3 h as found for the wildtype
virus, and NS1 levels remain impaired relative to wildtype throughout
the course of infection. NS2null mutants also show an early and
extreme defect in viral DNA ampliﬁcation (Cater and Pintel, 1992;
Cotmore et al., 1997; Naeger et al., 1990; Ruiz et al., 2006). The
molecular basis for this block is unknown, but there is no evidence for
direct involvement of NS2 in genome replication in vitro, and the
block must presumably occur after complementary strand synthesis,
since this is required to support the observed NS1 expression.Mutants
that express low levels of NS2 also exhibit a late defect in A9 cells,
which manifests as a reduction in progeny virus production resulting
from impaired capsid assembly (Cotmore et al., 1997; Ruiz et al.,
2006). This defect appears linked to the ability of NS2 to bind the
nuclear export factor Crm1 at high afﬁnity (Bodendorf et al., 1999;
Choi et al., 2005; Eichwald et al., 2002; Miller and Pintel, 2002). NS2 is
also known to bind several members of the 14-3-3 family members,
but the role of these interactions has yet to be determined (Brockhaus
et al., 1996).
During infection, replicating MVM DNA is ﬁrst detected in nuclear
sub-domains called autonomous parvovirus-associated replication
(APAR) bodies, which contain most of the available NS1 and a variety
of cellular proteins involved in viral DNA ampliﬁcation (Bashir et al.,
2001; Cziepluch et al., 2000). These foci are initially separate and
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promyelocytic leukemia (PML) oncogenic domains (PODs), Cajal
bodies, or speckled domains (Cziepluch et al., 2000; Young et al.,
2002), although they subsequently interact and sometimes merge with
these structures (Ihalainen et al., 2007; Young et al., 2002, 2005), as
accumulatingNS1 and viral DNA expand to occupymost of the enlarged
nucleus, leaving the cellular chromatin compacted and marginated
(Ihalainen et al., 2009). Thus, there appears to be initial separation of
nuclear domains, and differential segregation of cellular proteins into
the APAR compartment, which provides a window of time when is
possible to explore the cellular environment required to support viral
DNA ampliﬁcation by immunoﬂuorescent staining and microscopy.
Using a two-step (isoleucine deprivation/aphidicolin block) synchroni-
zation procedure, in which virus is allowed to penetrate into the cell
nucleus prior to S-phase release, we have previously characterized
sequential changes in the rates of cellular and viral DNA synthesis with
time in S-phase (Cotmore and Tattersall, 1987). The current experi-
ments were designed to initially correlate these phases in DNA
metabolism with progressive changes in intranuclear NS1 distribution,
and thus establish adevelopmental sequence forproductive infectionby
the wildtype virus that reﬂects time in S-phase.
A difference in the pattern of NS1 distribution was previously
observed in A9 cells infectedwithMVMwildtype andNS2nullmutants
(Ruiz et al., 2006). Speciﬁcally, while comparable numbers of APAR-
like structures were detected in both infections, these structures were
consistently smaller in NS2null infections, perhaps suggesting that
NS2 expressionmightmodulate the organization and/or development
of these viral replication centers. In this paper we have used the
classiﬁcation scheme for NS1 progression described above to charac-
terize andquantify the defect in APARbodymaturationduringNS2null
infections, and then explored their organization, looking for defects in
the recruitment of speciﬁc constituent proteins in the absence of NS2.
The speed and severity of the DNA replication block seen for
NS2null mutants in A9 cells suggested either a profound inability to
recruit compatible replication machinery, or perhaps the induction of
an antiviral state, such as might accompany activation of a DNA
damage response (DDR). MVM replication mechanisms have been
studied extensively in vitro (reviewed in Cotmore and Tattersall,
2006a,b), but such studies have relied on cellular proteins derived
from uninfected cells or generated from expression vectors, so that
the potential effects of induced damage responses have not been
explored. However, the alien structure of incoming, uncoated, viral
genomes could potentially evoke such responses, and viral DNA is
replicated via a unidirectional, leading-strand speciﬁc, displacement
mechanism called “rolling hairpin replication” that displaces long
stretches of single-stranded DNA and generates a series of blunt-
ended duplex intermediates, either of which would be expected to
elicit DNA repair. Since this quasi-circular mechanism relies predomi-
nantly on cellular synthetic machinery, aided and orchestrated by the
viral NS1 protein, it would be potentially susceptible to such changes
in replication control, and the virus would likely have evolved to
combat or suborn whatever cellular responses it induces. There is a
growing body of evidence that DNA viruses typically do evoke, and
then counter, cellular damage responses, although speciﬁc details
vary greatly between viruses (reviewed in Lilley et al., 2010;
Weitzman et al., 2010). Accordingly, we looked for evidence of
induced damage responses, assessed whether activated proteins were
recruited to the viral replication compartment, and determined if NS2
expression inﬂuenced this process.
Results and discussion
Distinct patterns of NS1 organization emerge with time in S-phase nuclei
Our ﬁrst study was designed to correlate phases in DNA
metabolism previously observed in MVM infected cells during S-phase, with changes in nuclear NS1 morphology. Accordingly, we
used a two-step cell synchronization procedure that allows virus to
enter the cell and penetrate to the cell nucleus before release of the
DNA replication block. Using this same procedure, we had previously
shown that DNA synthesis rates in MVM infected A9 cells parallel
those in uninfected cells for the ﬁrst 2 h in S phase, but then
progressively drop to almost pre-release levels over the next 4 h. Viral
NS protein expression becomes apparent by around 3 h post-release
under these conditions, but a new wave of DNA synthesis, reﬂecting
the ampliﬁcation of duplex viral DNA, is not observed until 5–6 h into
S, peaks at 10 h, and then remains relatively steady following the
onset of progeny virus release (Cotmore and Tattersall, 1987). In the
current experiments NS1 expression was monitored by indirect
immuno-ﬂuorescence and confocal microscopy in cells infected with
wildtypeMVMp at a multiplicity of 3000 genome-containing particles
per cell (g/cell), and ﬁxed at 3, 6, 12 and 24 h after release into S-
phase. During this period the pattern of nuclear NS1 staining
progressed through characteristic stages, allowing us to derive a
classiﬁcation scheme that tracked its redistribution with time in a
productive infection. Fig. 1 shows representative cells belonging to
each class.
At the 3 h time point, NS1wasmost commonly observed as a cloud
of tiny puncta spread throughout the nucleus, but absent from
nucleoli, as shown in the ﬁrst panel of Fig. 1A (Class 0). However, even
at this early time, in some cells individual foci were larger and stained
more intensely, creating a series of distinct speckles, whichwe termed
developmental Class I foci (Fig. 1A). By 6 h into S-phase, the intensity
of NS1 staining in the nuclei increased, and it became sequestered in a
limited number of progressively larger distinct foci (Class II), although
such nuclei also contained a population of smaller puncta that
resembled those seen in the earlier Class I nuclei. This Class II
distributionmatured to a pattern containing fewer and larger, but still
discrete, NS1 bodies (Class III), while at later times a staining pattern
in which NS1 occupied the entire nucleoplasm predominated (Class
IV). Classes II and III in this scheme correspond to the previously
characterized APAR foci. This time frame indicates that APAR bodies
are relatively short-lived, emerging as the cell embarks on the major
phase of viral DNA ampliﬁcation at around 6 h into S-phase, but are
lost within a few hours during a productive infection, as the nucleus
rapidly ﬁlls with viral products. A very similar developmental
sequence was observed in NLFK cells infected with canine parvovirus
(Ihalainen et al., 2007), suggesting that this rapid progression is
characteristic for members of the genus Parvovirus. In contrast, when
NS1 was expressed by transfection, all NS1-positive nuclei belonged
to either Class I, showing dozens of distinct small speckles, or Class IV,
where the entire nucleoplasm was ﬁlled with NS1 (Fig. 1B), but the
intermediate APAR clustering patterns were absent. Thus, maturation
through APAR-like intermediates only occurs during infection, and
correlates in time with the onset of rapid viral duplex DNA expansion.
APAR centers are established in NS2null infections, but fail to mature
To document the effects of NS2 on this sequence of events, we
carried out a kinetic analysis in synchronized cells, usingwildtype and
two NS2 mutant MVMp viruses, as shown in Figs. 1C, D and E. One of
the mutants expressed no stable NS2 due to a mutation at residue 86
(NS2-am) that effectively prevents expression and/or accumulation
of the truncated product (Cotmore et al., 1997; Gersappe et al., 1999;
Naeger et al., 1992; Ruiz et al., 2006), while the other expressed
approximately one sixth of the total wildtype NS2 level (NS2low).
Since NS1 expression cannot be detected until 6 h post-release in
cells infected with NS2null viruses (Ruiz et al., 2006), cells were ﬁxed
at 6, 12 and 24 h after release from aphidicolin, stained for NS1, and
blind-scored according to the classes identiﬁed in Fig. 1A. At 6 h into
S-phase NS1-positive cells predominantly exhibited the Class I
distribution pattern, although some class II nuclei were apparent in
Fig. 1. Changes in the nuclear morphology of NS1 with time in S-phase. A. A classiﬁcation scheme, with Classes 0–IV, was developed to describe the progressive changes in NS1
morphology that emerge with time after synchronized A9 cells infected with wild type MVMp are released into S-phase. Overall classes 0 and I were ﬁrst observed 3 h into S-phase,
class II at 6 h, and classes III and IV at 12 h, although the number of cells exhibiting the later class morphologies progressively increased with time. B.When expressed by transfection,
NS1 adopts the Class 0–I, or Class IV distribution, with no intermediate forms. C–E. Kinetic analysis of NS1 redistribution in A9 cells infected with wildtype or NS2 mutant viruses at
6 h (C), 12 h (D), and 24 h (E) after release into S-phase.
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developmental patterns emerged. In cells infected with either the
wildtype or NS2low viruses, the NS1-staining pattern progressed to
the Class IV stage in almost 80% of infected cells by 12 h post-release
(Fig. 1D). In contrast, a similar percentage of cells infected with
NS2null viruses showed evidence of NS1 expression, but staining
generally failed to progress beyond the Class II stage by 12 h post-
release, and this defect persisted through 24 h after release (Fig. 1E).
This indicates that in NS2null infections NS1 foci are established and
develop normally during early S-phase, but the NS2null phenotype
rapidly emerges at around 6 h post-release, with the onset of viral
DNA ampliﬁcation. It also suggests that APAR progression is not
merely retarded, but is effectively blocked in all but a small
percentage of cells infected with NS2null viruses, even though cells
with class II/III nuclei have been reported to survive for several days
in culture (Young et al., 2005). We conclude that the presence of NS2
had a major impact on APAR development in MVM-infected cells,
although only relatively low levels of the protein are required since
even one sixth of the wildtype concentration, expressed from the
NS2low mutant, was compatible with normal maturation and
progression. This data highlights the possibility that the APAR defect,
and the failure of NS2null mutants to replicate viral DNA effectively,
may reﬂect critical abnormalities in the organization of the early viral
replication compartment.
NS2 is not required for recruitment of replication factors to APAR foci
To explore whether the accumulation of replication factors
known to be recruited to wildtype APAR bodies was dependent
upon NS2, asynchronous populations of A9 cells were infected with
wildtype and NS2null virions (3000 g/cell) under single round
infection conditions, ﬁxed and processed for immunoﬂuorescence
24 h post infection using antibodies directed against a range of
known APAR body constituents. Cellular replication factors known to
be essential for MVM replication, exempliﬁed here by RPA and
PCNA, co-localized with NS1 in APAR bodies as previously reported(Bashir et al., 2001; Cziepluch et al., 2000) in cells infected with both
wildtype and NS2null viruses, as shown in Fig. 2. The lagging strand
DNA polymerase pol-α is also known to be recruited to APAR foci in
wildtype infections, even though this enzyme is not required for
MVM DNA synthesis in vitro (Bashir et al., 2001; Christensen and
Tattersall, 2002). Recruitment of this seemingly irrelevant factor
suggests that parvoviruses may usurp pre-existing cellular replica-
tion complexes, rather than accumulate individual components
(Bashir et al., 2001), as discussed later. However, as shown in
Fig. 2, pol-α was detected in APAR bodies in both wildtype and
NS2null infections. Normally pol-α exists as a complex with primase,
a DNA-dependent RNA polymerase, but published data suggests that
this interaction may be disrupted in MVM infected cells, leading to
the accumulation of a primase-free form of pol-α, which could
potentially impede bidirectional cellular DNA synthesis and thus
explain its cessation following viral infection (Gupta and Faust,
1993; Ho et al., 1989). However, in the current study the primase
component was readily detected and similarly sequestered in APAR
foci in both wildtype and NS2null infections, suggesting that this
holo-enzyme is recruited in an NS2-independent fashion. Likewise,
cyclin A is recruited into APAR foci in both wildtype and NS2null
infections (Fig. 2). Cyclin A is essential for the duplex conversion of
single-stranded MVM genomes by cellular replication extracts in
vitro, via a mechanism that requires its associated cyclin dependent
kinase activity (Bashir et al., PNAS 2000). Its precise role(s) in the
APAR compartment remains uncertain, but it has been suggested
that this sequestration might effectively render it inaccessible for
cdk1 activation in G2, thus preventing cell cycle progression (Bashir
et al., 2001). If so, the constrained size of APAR foci in NS2null
infections could render cyclin A sequestration less efﬁcient, even
though it is effectively recruited. However, the control of cell cycle
progression during MVM infection is likely complex, since expres-
sion of NS1 alone has been shown to impede cellular DNA
replication in some cell types, leading to arrest in S and G2 phases
of the cell cycle (Op De Beeck and Caillet-Fauquet, 1997; Op De
Beeck et al., 2001).
Fig. 2. Co-localization of cellular replication proteins with NS1 in APAR foci during infection with wild type and NS2 mutant MVM.
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replication factors into the APAR compartment proceeds similarly in
wildtype and NS2null infections, arguing against the possibility that
the defect underlying APARmaturation and the DNA replication block
seen in NS2null infections, results from failure in the organization of
nascent APAR compartments.
RPA 32 kDa subunit is hyper-phosphorylated during MVM infection
Finding no differences in the qualitative re-localization of known
cellular replication factors in wildtype and NS2null infections, we
extended this analysis to include modiﬁed proteins that might be
induced in response to DNA damage (reviewed in Huen and Chen,
2010; Jackson and Bartek, 2009). Displacement synthesis from the
unidirectional MVM fork is totally dependent upon the availability of
high concentrations of RPA (Christensen and Tattersall, 2002), so that
damage-mediated phosphorylation of this complex might severely
impact its synthesis. RPA is a heterotrimeric complex, composed of
RPA70, RPA32 and RPA14 subunits. The RPA32 subunit is phosphory-
lated at speciﬁc sites by cyclin-dependent kinases when cells enter S-
phase, but there are also seven residues in its extreme N-terminusthat can become phosphorylated in response to DNA damage (Nuss
et al., 2005; Olson et al., 2006).
Accordingly, we asked if the RPA32 subunit in wildtype and
NS2null infections carried DDR-induced PI3K-like kinase concensus
and non-consensus phosphorylations, and if so whether such
complexes were still recruited to APAR foci. As shown in the top
two panels of Fig. 3A, indirect immunoﬂuorescence with phospho-
speciﬁc antibodies revealed accumulation of RPA32 phosphorylated at
the non-consensus serine 4 and 8 sites and at the consensus serine 33
site in both wildtype and NS2null infected cells, which substantially
colocalized with NS1 in APAR foci. This pattern of induction was
conﬁrmed by Western analysis, discussed later, and supported the
suggestion that uncoated viral genomes and/or viral replication could
elicit response from the cell's damage surveillance and repair
machinery. This prompted us to broaden our investigation to look
for additional evidence of damage responses.
γH2AX/MDC1 DNA damage foci associate with APAR bodies
A wave of histone H2AX phosphorylation at Ser-139, generating a
product referred to as γH2AX, can spread very rapidly for many
Fig. 3. Co-localization of cellular DNA damage response proteins with NS1 in cells infected with wildtype and NS2 mutant viruses.
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DNA, creating DNA damage foci (DDF) that are large enough to be
observed by immunoﬂuorescence microscopy (Fernandez-Capetillo
et al., 2004; Rogakou et al., 1998). As seen in the third panel of Fig. 3A,
and at higher magniﬁcation in Fig. 3B, γH2AX foci developed in close
association with the APAR compartment during both wildtype and
NS2null infections, at ﬁrst seeming to surround, rather than colocalize
with, the accumulated NS1. However DDF and APAR foci thenmerged,
and γH2AX-staining lost its previous punctate appearance as it
accumulated to high concentration in the developing APAR compart-
ment. Ultimately, in cells with a class IV pattern of NS1 staining, viral
replication was associated with major overall intensiﬁcation of the
γH2AX signal, as seen, for example, in the two cells at the top of the
wildtype sample in the third panel of Fig. 3A, but co-localization even
extended to some of the very smallest, class I, NS1 foci seen in the
lower cell in this panel, where overall signal ampliﬁcation appeared as
yet minimal. We conclude that γH2AX damage foci are highly
enriched in the immediate vicinity of developing APAR bodies in
both wildtype and NS2null mutant infections, and that the modiﬁedhistone becomes assimilated into the APAR compartment where it
effectively co-localizes with accumulated NS1. It is hard to envisage
how γH2AX foci of this size could be organized without a DNA core,
but individual viral genomes in the process of being trafﬁcked to the
APAR compartment would not be distinguishable at this magniﬁca-
tion. Thus, it seems possible that these γH2AX foci became organized
on cellular DNA, which in turn suggests that damaged host DNA may
be speciﬁcally relocated to developing MVM replication centers and/
or that the virus induces damage responses in surrounding normal
cellular DNA, and is then able to organize transfer of the modiﬁed
histone into the MVM compartment. Both scenarios suggest close
juxtaposition of APAR foci and cellular DNA in this early phase of
ampliﬁcation, allowing directional transfer of components.
During cellular damage responses H2AX phosphorylation creates
binding sites that recruit Mediator of DNA Damage Checkpoint 1
(MDC1), a multi-domain molecular platform that, in turn, binds and
stably accumulates a variety of effector and transducer molecules.
These serve multiple essential roles in relaxing chromatin structure,
and in amplifying and propagating various arms of the damage
Fig. 4. Accumulation of γH2AX and MDC1 DNA damage response foci around APAR
bodies in mouse embryonic ﬁbroblasts. A, B. WT and H2AX MEFs were stained as
indicated. Stippled vertical bars in the middle panel of section A and in section B
indicate the juxtaposition of two separate images. The lower panel in section A shows
NS1 and MDC1 staining at a higher magniﬁcation. Panel C conﬁrms the loss of H2AX
expression in the H2AX-KO MEFs by differential staining with antibodies against H2AX
and MDC1.
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central role in the development of cellular γH2AX repair foci. DDR foci
containing MDC1 were also commonly observed clustered around
developing class II APAR bodies (as in the NS2null sample shown in
Fig. 3A), but, unlike γH2AX, MDC1was not conspicuously sequestered
inside the APAR compartment in either wildtype or NS2null
infections. Instead, late stage (NS1 types III–IV) nuclei contained
very few discrete MDC1 foci, but did stain diffusely for this protein,
and Western analysis (detailed below) suggested that the overall
MDC1 concentration in the cell did not change appreciably within the
ﬁrst 24 h of infection.
Thus in A9 cells γH2AX colocalized with even the smallest MVM
APAR foci in both wildtype and NS2null infections, and then remained
associated with the developing viral replication compartment,
whereas MDC1 foci segregated around type II viral bodies but MDC1
did not conspicuously accumulate within the APAR compartment.
This contrasting sequence of events was even more apparent in
mouse embryonic ﬁbroblasts (MEFs), as illustrated in Fig. 4A. In these
wildtype MEFs large clusters of MDC1 foci commonly surrounded
type II/III NS1 foci, as seen at higher magniﬁcation in the bottom row
of panels, whereas cells with a type IV NS1 distribution (as seen in the
second row) showed no sign of MDC1 accumulation, in sharp contrast
to the major overall γH2AX accumulation seen in type IV nuclei
(upper panel). If this reﬂects speciﬁc inclusion of γH2AX within the
viral replication compartment, but the exclusion of MDC1, such
disruptionmay imply a sortingmechanism that could potentially limit
aspects of the normal damage cascade. As a control, we show, in
Fig. 4B, that APAR bodies are generated during MVM infection of
H2AX knock-out MEFs, so that APAR center development is not
dependent upon factors delivered via recruitment of these damage
foci. However, as would be predicted, such cells failed to show
induction or APAR body recruitment of MDC1-containing foci.
Whether or not sequestration of γH2AX, or associated damage
response proteins, in the vicinity of replicating viral DNA is beneﬁcial
or detrimental to virus replication remains to be explored. Fig. 4C
serves as a control for Fig. 4B, and documents that MDC1 staining is
distributed throughout the nucleus of these wildtype and H2AX−/−
MEFs whereas, as would be expected, H2AX staining is absent from
H2AX−/− nuclei. Overall, this data indicates that at the start of the
major phase of viral DNA ampliﬁcation, cellular γH2AX/MDC1 DNA
damage foci are speciﬁcally induced and/or recruited to the vicinity of
the viral replication compartment, where they lose their focal
appearance, individual components appear to dissociate, and at
least some components become sequestered in close apposition to
replicating viral DNA.
Quantitative assessment of damage responses during MVM infection
In order to assess which damage response pathways were
activated during MVM infection, and to ask whether they were
conspicuously implicated in the NS2null defect, we probed Western
transfers with a series of diagnostic antibodies, and quantiﬁed the
signals using indirect immunoﬂuorescence. Cellular responses to DNA
double-strand breaks or collapsed replication forks involve a complex
series of signal transduction cascades in which lesions are detected by
sensor proteins that in turn activate members of the phosphoinositide
3 kinase-like protein kinase (PI3KK) family, speciﬁcally ATM (ataxia
telangiectasia mutated), ATR (ATM and Rad3-related) and DNA-PK
(DNA-dependent protein kinase). Which particular kinase is activated
depends on several factors, predominantly the nature of the DNA
lesion and the stage of the cell cycle. Thus, double-strand breaks in S-
phase typically activate ATM, while single-stranded DNA, often
associated with collapsed cellular replication forks, leads to activation
of ATR. However, these cascades are complex and overlapping, with
certain transducers and effectors involved in multiple pathways. As a
positive control for these experiments uninfected A9 cells wereexposed to the topoisomerase I inhibitor camptothecin. We also used
a speciﬁc inhibitor of ATM activation (2-morpholin-4-yl-6-thianth-
ren-1-yl-pyran-4-one, Kudos 55933) that is at least 100-fold more
active against ATM than against related kinases (reviewed in
O'Connor et al., 2007), to probe the complexity of virus induced
responses. This inhibitor was ﬁrst screened for cytotoxicity in A9 cells
at drug concentrations from 2.5 to 10 μM, using a “Live/Dead” assay
based on differential calcein AM/ethidium homodimer staining, and
showed little evidence of inducing cell death over the time course
used for theWestern assays (Fig. 5A). However, parvoviruses can only
initiate infection in cells that enter S-phase under normal cell cycle
control. Thus, inhibitors that do not kill the cell but do impede cell
cycle progression can be erroneously scored as inhibiting speciﬁc
aspects of viral infection. To assess the effect of Kudos 55933 on the
rate of entry into S-phase, uninfected A9 cells were incubated under
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analogue Edu immediately prior to ﬁxation. Incorporated Edu was
visualized using “Click-it” chemistry and ﬂuorescence microscopy. As
seen in Fig. 5B, the percentage of cells actively engaged in DNA
synthesis remained constant for drug concentrations up to 5 μM, but
was suppressed by approximately 40% at higher doses. This assay wasperformed multiple times, and consistently gave results comparable
to those illustrated in Fig. 5B, indicating that in uninfected
asynchronous A9 cells exposure to concentrations of inhibitor in
excess of 5 μM for 24 h slowed cell cycle progression. We therefore
selected 5 μM as our standard working concentration.
ATM kinase is activated in response to MVM infection
Asynchronous cells were infected under single cycle conditions,
harvested at 24 h post infection, and probed with antibodies directed
against a variety of candidate factors. In the experiment illustrated in
Fig. 5C, cells were infected for 4 h at 10,000 g/cell with wild-type
MVMp and two related NS2null mutants, NS2−am and NS2−sam, the
latter being the NS2−am mutant with an additional major splice
acceptor site mutation (Cotmore et al., 1997). To assess infection
initiation frequency, parallel samples were analyzed for NS1 expres-
sion by indirect immunoﬂuorescence microscopy. These results,
tabulated at the bottom of Fig. 5C, indicate that the infections were
matched at the level of overt initiation, with around ~50% of cells in
each sample showing conspicuous NS1 accumulation by 24 h post
infection. As expected, neither of the NS2null mutants gave evidence
of NS2 accumulation, and both showed similar levels of NS1, which
were approximately 3-fold lower than levels seen in the wildtype
infection (Fig. 5C, panels a and b). For each virus, exposure to the
ATM-inhibitor impaired NS1 accumulation somewhat (by 17–35%),
and generally had a more marked effect on NS2 expression in the
wildtype infection (53% impaired). This pattern of inhibitor-mediated
suppression of viral protein accumulation was seen in multiple
experiments, perhaps suggesting that ATM activation may promote
the efﬁciency of early stages in viral replication that are required for
the generation of transcription templates or some aspect of viral gene
expression.
Probing extracts with an antibody speciﬁc for the ATM autopho-
sphorylation site (generally referred to as ATM-p-ser1981, although
this speciﬁes the equivalent position in human ATM) suggested that
ATM was activated in all infections (Fig. 5C, panel c). By comparison
with uninfected control cells phosphorylated ATM was found to be
induced approximately 11-fold in the positive, camptothecin-treated,
control sample and this was readily inhibited by Kudos. In contrast,
both wild-type and mutant MVM infections induced ATM activation
to somewhat lower levels (2.5 to 5.5-fold induction), but this could
not be totally abrogated by the ATM-inhibitor (29–36% inhibition). As
a control, we show that total ATM accumulation remained essentially
similar in all samples (Fig. 5C, panel d). Why virus-induced activation
resists this inhibitor remains uncertain. We explored the effects of
adding Kudos 55933 at higher doses (10 μM), or 4 h earlier (i.e. 4 h
prior to infection), but without quantitatively inhibiting ATM
autophosphorylation (data not shown). We also considered the
possibility that using lower virus inocula might render the response
easier to dissect, but similar results were obtained with virus inputFig. 5. Infection with wildtype and NS2 mutant MVM induces similar DNA damage
responses in asynchronous A9 cells. A. Effects of Kudos 55933 on A9 viability.
Uninfected A9 cells were screened for cell viability in the presence of variable doses of
Kudos 55933 using a ﬂuorescence based Live/dead cell assay (Biotium). B. Effects of
Kudos 55933 on cell entry into S-phase. Uninfected A9 cells were assessed, by “Click-It”
chemistry and ﬂuorescence microscopy, for their ability to enter S-phase and
incorporate EdU after exposure to variable doses of Kudos 55933. C. Western
quantitation of DNA damage response following MVM infection. Lanes 1 and 2 contain
extract from camptothecin (camp)-treated cells; lanes 3 and 4 from uninfected (NCC)
cells; lanes 5 and 6 from cells infected with wild type MVM; lanes 7 and 8 from NS2-am
infected cells; and lanes 9 and 10 from NS2-sam infected cells. Extracts in lanes, 2, 4, 6,
8 and 10 also received the ATM-inhibitor, Kudos 55933 (ATMi) at 5 μM. The percent of
NS1 positive cells in each infection (lanes 5–10) is shown at the bottom of the ﬁgure,
with standard deviations. Band intensities, plotted under certain panels, are expressed
as ﬂuorescence units’ ×105. Band intensities for upper and lower bands of RPA32 ser33
were quantiﬁed separately.
382 Z. Ruiz et al. / Virology 410 (2011) 375–384multiplicities of 2000 and 400 genomes per cell (resulting in NS1
positive initiation frequencies of around 30% and 10%, respectively,
data not shown). However, at present we have been unable to
consistently suppress ATM phosphorylation at its autocatalytic site
during asynchronous infections using inhibitor doses that are
compatible with normal entry into S-phase, and suggest that this
might, at least in part, reﬂect an unusual mode of phosphorylation or
longevity of the activated kinase, as recently demonstrated during
SV40 infection of CV1 cells (Rohaly et al., 2010).
Overall, we conclude that both wildtype and NS2null viruses
induce conspicuous phosphorylation at a site in the ATM molecule
which critically regulates its oligomerization and thus its activity, and
that this phosphorylation is at least partially inhibited by a highly
speciﬁc ATM kinase inhibitor. Since viral DNA ampliﬁcation in NS2null
infections is minimal, and NS1 accumulation is reduced, it is
remarkable that the mutant viruses activated ATM so effectively,
again suggesting that early events in the viral life cycle are particularly
prone to induce this damage response.
ATR phosphorylation at serine 428 is downregulated in response to MVM
infection
In contrast to ATM, the ATR kinase appeared to be phosphorylated
at its activating site (serine 428) in asynchronous A9 cells (Fig. 5C,
panel e), although accumulation of this form could still be enhanced
by exposure to camptothecin. Thus, it appears that ATR activationmay
be somewhat atypical in these cells, but the pathway remains
functional. Signiﬁcantly, the anti-phospho-ATR antibody used in
these blots gave diffuse staining in both uninfected and infected A9
cells, but in wild-type MEFs staining with the same antibody co-
localized with NS1 in APAR bodies (data not shown), supporting the
suggestion that ATR regulation may be somewhat atypical in A9 cells.
When assessed by Western blotting 24 h post infection in asynchro-
nous A9 cells, both wild-type and NS2null MVM caused its down-
regulation by ~2-fold, while overall levels of total ATR remained
relatively constant (Fig. 5C, panel f). This downregulation was
observed repeatedly, correlated inversely with virus input (data not
shown), and was not inﬂuenced by the ATM inhibitor. Since NS1
expression was observed in ~50% of cells, and there was an ~2-fold
reduction in ATR-phospho-ser428 accumulation, it is theoretically
possible that infection totally suppressed ATR phosphorylation in the
infected cell population.
H2AX phosphorylation is reduced in NS2null compared to wildtype
infection
As expected from the confocal analysis, H2AX phosphorylation
was markedly induced in all infected samples relative to uninfected
control cells (Fig. 5C, panel g), but this was strongest for the wildtype
virus (~11-fold), while NS2null viruses only upregulated its phos-
phorylation ~6-fold. Camptothecin-treated positive control cells also
showed H2AX activation (~6-fold), which was again reduced to
background levels by addition of the ATM inhibitor. Although, Kudos
55933 only partially suppressed H2AX phosphorylation in infected
cells, this did parallel levels of residual ATM-p-ser1981, suggesting
that ATM was likely responsible for much of the γH2AX induction. In
contrast, total levels of both H2AX and MDC1 remained similar in all
samples (Fig. 5C, panels h and n. Thus, overall we ﬁnd clear evidence
of virus induced γH2AX induction, and this response is somewhat
tempered, but not either eliminated or potentiated, in infections with
NS2null mutants.
RPA32 is hyper-phosphorylated at multiple residues in infected cells
Confocal analysis indicated that complexes containing RPA32
phosphorylated at the PI3kinase-like-kinase consensus (Ser-33) andnonconsensus (Ser-4 and Ser-8) sites were both relocated to viral
replication centers. RPA32 phosphorylation at non-consensus sites
(e.g. at residues 4, 8, 11, 12 and 13) has been shown to generate a
slower migrating form of RPA32, perhaps indicating induction of a
conformational change in the protein, while phosphorylation of the
consensus Thr-21 (TQ) and Ser-33 (SQ) sites has onlyminor effects on
protein migration (Olson et al., 2006). Thus, by western analysis we
were able to detect both individual and complex phosphorylation
events. In camptothecin-treated control samples, a single, retarded,
band was detected with the RPA32 Ser-4/8 antibody (Fig. 5C, panel k),
which was substantially enhanced by addition of the ATM kinase
inhibitor (2.4-fold), suggesting complex cross-talk between damage
response pathways in this situation. In contrast, the RPA32 Ser-33
antibody detected two distinct species following exposure to
camptothecin, a predominant lower band indicating the presence of
molecules that did not have additional non-consensus modiﬁcations,
and a slower band indicating the presence of multiple damage-
induced phosphate additions (Fig. 5C, panel l). In this case, the ATM
inhibitor only enhanced overall Ser-33 accumulation by around 25%,
but again drove it into the slower form, conﬁrming that in this case
ATM inhibition allowed the subunit to be phosphorylated at
additional non-consensus sites.
While neither antibody reacted with extracts from uninfected
cells, all virus infections led to potent RPA32 phosphorylation at both
consensus and non-consensus sites. Moreover, because the Ser-33
speciﬁc antibody only detected species with retardedmigration, these
must all carry additional non-consensus phosphorylations. Unlike the
camptothecin control, in infected samples addition of Kudos 55933
somewhat inhibited RPA32 phosphorylation, likely suggesting a role
for the ATM kinase in its accumulation. Strong induction of
phosphorylation at non-consensus sites was also apparent when
samples were probed with an antibody that recognized all forms of
RPA32 (Fig. 5C, panel m). In this case extracts from uninfected and
camptothecin-treated cells exhibited relatively low levels of the upper
band (1.5% and 1.8% of the total RPA32, respectively), as did a
hydroxyurea-treated control (data not shown), whereas all MVM
infected samples showed more extensive conversion to the slower
form (4.1–7.4% of the total RPA32). Thus MVM infection induces
unusually high levels of non-consensus RPA32 phosphorylation, but
these levels were remarkably similar in wild-type and NS2null
infections. This suggests that critical inducing events occur early in
the viral life cycle, and that the presence of NS2 may have minimal
effects on the extent and/or speciﬁcity of these modiﬁcations.
Overall the western data supports our confocal analysis, showing
that by 24 h post infection MVM induces major DNA damage
responses in its host that must markedly impact the available
replication machinery, and which the virus must exploit and/or
circumvent. However, these studies do not suggest a major role for
NS2 in the induction or evasion of these modiﬁcations, or in the
organization of the viral replication compartment. We originally
chose to avoid synchronization procedures in the APAR organization
studies, since aphidicolin alone would be expected to induce ATR
responses, but such analyses will likely be required to help distinguish
early and late effects during, and preceding, viral duplex ampliﬁca-
tion, and to avoid potential complexity from responses evoked in cells
that initiate replication late in S-phase. Since we observed no
dislocation in the organization of cellular proteins in the APAR
compartment during NS2null infections, failure to routinely develop
beyond class II in our NS1 classiﬁcation schememay indicate that such
progression is predominantly driven by the onset of rapid duplex DNA
ampliﬁcation. If so, class I and II stages in this scheme represent an
early phase in viral infection when essential factors are recruited and
the composition of the replication compartment established. How
H2AX damage foci, and presumably cellular DNA, become organized
around developing APAR foci, and whether the retained histone
serves any speciﬁc purpose, or must merely be removed from the
383Z. Ruiz et al. / Virology 410 (2011) 375–384cellular environment at this time, pose interesting questions for
future analysis.
Materials and methods
Cells and viruses
The prototype strain of MVMp and its mutant derivatives NS2−am
and NS2−sam (previously called NS2-F86 and NS2-SA86, respectively,
Cotmore et al., 1997), and NS2wam and NS2low (previously called
NS2P−/Y+ and Plo/Y− respectively, Ruiz et al., 2006) were propa-
gated in the SV40-transformed newborn human kidney cell line 324K.
Viral stocks were puriﬁed by centrifugation through iodixanol
(Optiprep, Axis-Shield, Oslo, Norway) step gradients, as previously
described (D'Abramo et al., 2005) and quantiﬁed by Southern blot
against knownamounts of genome-length viral DNA. For experiments,
speciﬁed virion multiplicities expressed as genome equivalents per
cell (g/cell), were used to infect themouse L cell derivative A9 ouabr11
or embryonic ﬁbroblasts from normal or H2AX knock-out C57Bl/6
mice (MEFs, the gift of Dr. Junjie Chen, generated as in Minter-
Dykhouse et al., 2008) cultured inDulbecco'smodiﬁed Eagle'sminimal
medium (DMEM) containing 5% and 10% fetal bovine serum, for A9s
and MEFs respectively. Although we did not titer the viral stocks used
in this paper by assessing their plaque-forming ability, we estimate
that, for wildtype MVMp, an input multiplicity of 10,000 genomes
would correlate to between 2 and 5 PFU per cell, as determined on A9
cell monolayers. Experiments were conducted under asynchrononous
conditions or, in A9s, after synchronization using an isoleucine
deprivation/aphidocolin double block schedule described previously
(Cotmore et al., 1997). For transfection experiments, NS1 was
expressed under the control of a CMV promoter in pCDNA3.1
(Invitrogen; MVM nucleotides 240-2291), using Superfect (Qiagen).
Confocal imaging
For confocalmicroscopy, cellswere seededonto coverslips in 35 mm
dishes at a density of 2.9×105 cells per dish and synchronized, or not, as
detailed in text. At the indicated times post infection, cells were ﬁxed
in 2.5% paraformaldehyde, permeabilized with PBS containing 0.1%
NP-40 and processed for indirect immunoﬂuorescence. NS1 was
detected using CE10, a mouse monoclonal antibody directed against
the MVM NS1 C-terminus (Yeung et al., 1991) or with a rabbit
polyclonal serumdirected against the C-terminal 16 amino acids of NS1
(Cotmore and Tattersall, 1988), and cells were counterstained with
4-6-diamidino-2-phenylindole (DAPI) and the following commercial
antibodies: PCNA (FL-261, Santa Cruz); Pol-alpha (N19, Santa Cruz);
DNA primase (p49 Biomeda); Cyclin A (H432, Santa Cruz); total RPA32,
Phospho RPA32 S4/S8, and Phospho RPA32 S33, Bethyl Laboratories;
γH2AX clone JBW 301 (sci 139, Millipore). Mouse monoclonal
antibodies against total H2AX and MDC1, and a rabbit polyclonal
antibody against MDC1 were the gift of Dr. Junjie Chen. After
immunostaining and mounting, specimens were analyzed by confocal
laser microscopy (LSM 510) using a 63× objective, and were detected
using the 488- and 568-nm excitation lines of an argon–krypton laser.
Images were acquired andmodiﬁedwith the LSM 510 software version
2.8 and processed in Adobe Photoshop.
Western blots
A9 cells, seeded at 5×105 per 60-mm-diameter dish, were infected
with 10,000 g/cell of wild type or mutant MVMp for 4 h at 37 °C in
DMEM containing 1% fetal bovine serum and 20 mM HEPES, pH 7.3,
before the inoculum was removed and cultures transferred to fresh
medium containing 0.04 units/ml of neuraminidase (Clostridium perfri-
gens, Type V, Sigma) to remove surface virus and prevent re-infection.
Where speciﬁed, the ATM-inhibitor Kudos 55933 (Calbiochem) wasadded (at 5 μM,asdeterminedbelow) to cultures at the timeof infection
(from a 2000× stock in DMSO), and replenished following the medium
change at 4 h post infection. As a positive control for DNA damage,
uninfected cultures were exposed to Camptothecin at 1 μM for 3 h prior
to harvest. At 24 h post infection all cells were washed twice with ice
cold PBS and lysed in 1× lysis buffer (2% SDS, 10% glycerol, 62.5 mM
Tris–HCI, pH 6.8) containing 1×Complete, EDTA-free, Protease inhibitor
cocktail (Roche) and 1× PhosSTOP, phosphatase inhibitor cocktail
(Roche). Cell lysates were collected, boiled for 10 min, aliquoted and
stored at−80 °C.
Protein concentration was determined using a Pierce BCA Protein
Assay Kit (Thermo Scientiﬁc) and 20 μg aliquots (with added dyes and
100 mM DTT) loaded onto 4–15% Mini-Protean TGX gels (Bio-Rad).
After separation proteins were transferred to Hybond ECLmembranes
(GE healthcare). These were stained with Ponceau Red to conﬁrm
sample uniformity, and probed by indirect immunoﬂuorescence using
antibodies against the following: MVM NS1/2N-terminal peptide
(Cotmore and Tattersall, 1986); phospho-H2AX S139 (Cell Signaling);
phospho-ATM S1981 (Cell Signaling); phospho-ATR S428 (Cell
Signaling), total ATR (Abcam), total ATM (GeneTex), total RPA32,
Phospho RPA32 S4/8 and Phospho RPA32 S33 (Bethyl Laboratories).
Signal was developed using an ECL™ Plex Western blotting system
(GE Healthcare), including ECL Plex goat-α-mouse IgG Cy3 and goat-
α-rabbit IgG Cy5 secondary antibodies, and detected using a Typhoon
Trio Variable Mode Imager (GE Healthcare). ImageQuant TL 7.0 (GE
Healthcare) image Analysis Software was used for protein
quantitation.
Kudos 55933 toxicity and effects on cell entry into S-phase
Prior to use in the above experiment, the ATM inhibitor Kudos
55933 was screened for toxicity in A9ouabr11 cells using a Viability/
Cytotoxicity Assay kit for Animal Live & Dead Cells (Biotium, Inc.).
Uninfected cells were seeded onto glass spots on Teﬂon coated “spot-
slides” (Cell-Line Associates, Inc., Newﬁeld, NJ) at 20% conﬂuence
(3000 cells per spot), and exposed to a range of Kudos concentrations
over the time course, and under the culture conditions, used for
western assays. Viable cells were detected by their ability to convert
non-ﬂuorescent calcein AM to ﬂuorescent calcein, producing intense
green ﬂuorescence (excitation/emission ~495 nm/~515 nm). Dead
cells were identiﬁed by their ability to take up of ethidium
homodimers through their damaged membranes, causing a 40-fold
enhancement of red ﬂuorescence in dead cells (excitation/emission
~530 nm/~635 nm). Green and red ﬂuorescent cells were counted in
six ﬁelds per Kudos dose, and the percent of live cells plotted, with
standard deviations.
Kudos 55933 was also screened (at 2.5, 5, 7.5 and 10 μM) for
possible effects on the rate at which A9 cells entered S-phase under
the standard experimental regime used for western assays. Cells were
seeded at 3000 cells per spot on microscope slides. At 23 h post
infection 10 μM EdU (5-ethynyl-2′-deoxyuridine) was added, and
cells were ﬁxed with 2.5% paraformaldehyde 1 h later and processed
using Click-iT chemistry (Click-iT EdU Alexa Fluor High-Throughput
Imaging Assay) according to the manufacturer's instructions (Invitro-
gen). Percent EdU positive cells were counted in ten ﬁelds, and plotted
with standard deviations.
Determining the initiation efﬁciency of viral infection
A9 cells were seeded at 20% conﬂuence on Teﬂon coated spot-
slides, infected and cultured under the experimental regime used for
western assays, and ﬁxed at 24 h post infection with 2.5% parafor-
maldehyde. Following permeabilization in 0.1% Triton X-100, cells
were stained with the α-NS1 CE10 antibody, followed by AlexaFuor
594-conjugated goat anti-mouse IgG (Invitrogen) and Dapi. Images
were acquired using standardized exposures on a Nikon OptiPhot epi-
384 Z. Ruiz et al. / Virology 410 (2011) 375–384ﬂuorescence microscope ﬁtted with a Kodak digital camera driven by
MDS 290 software. Ten ﬁelds were counted per sample, using Adobe
Photoshop 6.0, and the percent of infected cells calculated by
comparing NS1-positive nuclei with the total number of DAPI-stained
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